SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation that cannabis rescheduling may be imminent, with some anticipating a resulting sector-wide surge. The community is actively discussing the potential impact of a presidential executive order on tax relief and banking access. Some investors are optimistic about a short squeeze, while others remain cautious due to the company's history.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending due to positive reactions to its AI and autonomy day, with discussions focusing on the potential of its new in-house AI chip and self-driving capabilities. The community is weighing the company's advancements against competitors like Tesla and speculating on a possible short squeeze. Some investors are concerned about cash burn and the timeline for seeing returns on these new technologies.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending due to the upcoming launch of BlueBird 6, marking a significant step towards a launch cadence of approximately every 45 days in 2026; this represents a shift from concept to operational deployment. The community is buzzing about the potential for a Starlink competitor and the company's long-term prospects, with some highlighting the high short interest and potential for a squeeze.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Aurora Cannabis is trending amidst reports that Trump may consider rescheduling marijuana, potentially affecting taxation and medical access. The community is discussing the potential impact of this policy change and whether it will be a "sell the news" event. Scanners continue to light up as cannabis tickers show increased interest in response to the news.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU is trending due to its active community and ongoing initiatives, particularly the upcoming availability of Kendu Spice on Amazon. The community is actively discussing the project's strong IRL presence and the numerous businesses being built around the KENDU brand. Many see it as a long-term play with a dedicated and growing community.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as speculation mounts around potential federal cannabis policy changes, specifically regarding rescheduling. Community chatter revolves around whether an executive order will materialize, with some anticipating a significant sector-wide surge while others remain cautiously optimistic due to past disappointments. The ETF's exposure to US cannabis companies positions it to potentially benefit from any regulatory easing.

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BridgeBio Pharma Inc

BBIO is trending due to analyst upgrades and positive sentiment around the launch of Attruby, with the community actively discussing its potential to outperform competitors and the impact of upcoming Phase 3 readouts. Community members are weighing its growth potential in the context of a potentially undervalued biotech, while also considering the potential for acquisition by a major pharmaceutical company. Actionable trade alerts highlight possible entry and exit points based on technical analysis.

Gunz

Gunz ($GUN) is trending amid community excitement about potential breakouts and large whale buys, with some eyeing a return to all-time highs. The token is also getting attention due to its association with the Off The Grid (OTG) web3 game on the Avalanche network ($AVAX), leading to discussions about its tokenomics and potential for quick gains.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power ($SMR) is trending due to discussions around its potential role in powering AI data centers and a recent agreement with the Tennessee Valley Authority, though concerns persist around its financial performance and Fluor's stake monetization. The community is weighing the company's regulatory advantages and the increasing need for SMR technology against factors like potential share dilution and competition in the sector. Recent analyst target price reductions and overall nuclear sector bearishness may also be contributing to the conversation.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending as the community discusses its recent dip despite strong earnings and positive AI revenue forecasts, with some attributing the downturn to margin concerns and sector rotation. Despite the drop, analysts are maintaining positive outlooks, leading to speculation about a potential rebound. Bullish investors see the dip as a buying opportunity, citing Broadcom's significant role in AI and a substantial order backlog.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

C4 Therapeutics, Inc. (NASDAQ:CCCC) Given Average Recommendation of "Moderate Buy" by Brokerages

C4 Therapeutics, Inc. (NASDAQ:CCCC - Get Free Report) has earned a consensus rating of "Moderate Buy" from the nine ratings firms that are presently covering the company, Marketbeat.com reports. One...

FY2028 EPS Estimates for C4 Therapeutics Lowered by Analyst

C4 Therapeutics, Inc. (NASDAQ:CCCC - Free Report) - Investment analysts at Brookline Capital Management decreased their FY2028 EPS estimates for C4 Therapeutics in a report issued on Thursday...

C4 Therapeutics (NASDAQ:CCCC) Issues Quarterly Earnings Results

C4 Therapeutics (NASDAQ:CCCC - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.44) EPS for the quarter, topping analysts' consensus estimates of ($0.47...

C4 Therapeutics, Inc. (CCCC) Reports Q3 Loss, Beats Revenue Estimates

C4 Therapeutics (CCCC) delivered earnings and revenue surprises of +6.38% and +72.77%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Amicus Therapeutics (FOLD) Beats Q3 Earnings and Revenue Estimates

Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of +41.67% and +2.61%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Precision Oncology Approaches Drive $312B Market Transformation

Precision Oncology Approaches Drive $312B Market Transformation Precision Oncology Approaches Drive $312B Market Transformation PR Newswire VANCOUVER, Oct. 17, 2025 USA News Group News Commentary...

C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Misses Revenue Estimates

C4 Therapeutics (CCCC) delivered earnings and revenue surprises of +2.63% and -0.57%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Ocugen (OCGN) Reports Q2 Loss, Misses Revenue Estimates

Ocugen (OCGN) delivered earnings and revenue surprises of +16.67% and -1.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

C4 Therapeutics, Inc. (CCCC) Reports Q1 Loss, Tops Revenue Estimates

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. The company was founded by James E. Bradner, Kenneth C. Anderson, Nathanael S. Gray and Marc A. Cohen in October 2015 and is headquartered in Watertown, MA.

CCCC
C4 Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CCCC News

CCCCC4 Therapeutics Inc